|
|
||||||||
The FASEB Journal, Vol 6, 3245-3252, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
J Purkerson and P Isakson
Department of Immunoinflammatory Disease Research, Searle Research and Development, St. Louis, Missouri 63198.
A characteristic feature of the humoral immune response is a switch from IgM to other Ig isotypes that typically occurs subsequent to a first exposure to antigen. Ultimately, isotype switching involves a DNA rearrangement that recombines a variable region gene, initially juxtaposed to the mu constant region gene (C mu), with a constant region gene located downstream of C mu. Isotype switching is controlled by T lymphocyte-derived cytokines, such as interleukin-4 (IL-4), gamma- interferon (gamma-IFN), and TGF beta, which direct B lymphocytes to switch to specific Ig classes. For example, IL-4, directs murine B cells to produce IgG1 and IgE, and human B cells to produce IgE and IgG4. IL-4 appears to direct switching to IgE and IgG1 by inducing transcription of the epsilon and gamma 1 constant region genes before switch recombination. However, IL-4 is not a sufficient stimulus for isotype switching, and additional signals are required to complete this process. This second signal can be provided by physical contact with activated T cells, which may involve, at least in part, ligation of the CD40 molecule. For murine B cells the second signal may also be provided by IL-5. Isotype switching in B lymphocytes may provide a useful model for directed DNA recombination in higher eukaryotes.
This article has been cited by other articles:
![]() |
F. J. Quintana, M. Pitashny, and I. R. Cohen Experimental autoimmune myasthenia gravis in naive non-obese diabetic (NOD/LtJ) mice: susceptibility associated with natural IgG antibodies to the acetylcholine receptor Int. Immunol., January 1, 2003; 15(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tangye, A. Ferguson, D. T. Avery, C. S. Ma, and P. D. Hodgkin Isotype Switching by Human B Cells Is Division-Associated and Regulated by Cytokines J. Immunol., October 15, 2002; 169(8): 4298 - 4306. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and E. Y. Denkers Protective Role for Interleukin-5 during Chronic Toxoplasma gondii Infection Infect. Immun., September 1, 1999; 67(9): 4383 - 4392. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Peakman and N. Maizels Localization of Splenic B Cells Activated for Switch Recombination by In Situ Hybridization with I{gamma}1 Switch Transcript and Rad51 Probes J. Immunol., October 15, 1998; 161(8): 4008 - 4015. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ghaffar, S. R. Durham, K. Al-Ghamdi, E. Wright, P. Small, S. Frenkiel, H. J. Gould, and Q. Hamid Expression of IgE Heavy Chain Transcripts in the Sinus Mucosa of Atopic and Nonatopic Patients with Chronic Sinusitis Am. J. Respir. Cell Mol. Biol., May 1, 1998; 18(5): 706 - 711. [Abstract] [Full Text] |
||||
![]() |
H. Kotanides and N. C. Reich Interleukin-4-induced STAT6 Recognizes and Activates a Target Site in the Promoter of the Interleukin-4 Receptor Gene J. Biol. Chem., October 11, 1996; 271(41): 25555 - 25561. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Kotanides and N. Reich Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4 Science, November 19, 1993; 262(5137): 1265 - 1267. [Abstract] [PDF] |
||||
![]() |
A Shahinian, K Pfeffer, K. Lee, T. Kundig, K Kishihara, A Wakeham, K Kawai, P. Ohashi, C. Thompson, and T. Mak Differential T cell costimulatory requirements in CD28-deficient mice Science, July 30, 1993; 261(5121): 609 - 612. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |